Page last updated: 2024-08-17

adenosine diphosphate and pazopanib

adenosine diphosphate has been researched along with pazopanib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshar-Kharghan, V; Armaiz-Pena, GN; Bottsford-Miller, J; Burns, AR; Cho, MS; Choi, HJ; Dalton, HJ; Gharpure, KM; Gutschner, T; Haemmerle, M; Han, HD; Hansen, JM; Lopez-Berestein, G; Mangala, LS; Nagaraja, AS; Nick, AM; Pecot, CV; Pradeep, S; Rupaimoole, R; Sood, AK; Stone, RL; Taylor, ML; Wu, SY; Zand, B	1

Other Studies

1 other study(ies) available for adenosine diphosphate and pazopanib

Article	Year
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. The Journal of clinical investigation, 2016, 05-02, Volume: 126, Issue:5 Topics: Adenosine Diphosphate; Animals; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Blood Platelets; Cell Hypoxia; Cell Line, Tumor; Female; Focal Adhesion Kinase 1; Humans; Indazoles; Mice; Mice, Knockout; Neoplasm Proteins; Neovascularization, Pathologic; Ovarian Neoplasms; Pyrimidines; Sulfonamides; Tumor Microenvironment; Xenograft Model Antitumor Assays	2016

Article

Year

FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal.

The Journal of clinical investigation, 2016, 05-02, Volume: 126, Issue:5

Topics: Adenosine Diphosphate; Animals; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Blood Platelets; Cell Hypoxia; Cell Line, Tumor; Female; Focal Adhesion Kinase 1; Humans; Indazoles; Mice; Mice, Knockout; Neoplasm Proteins; Neovascularization, Pathologic; Ovarian Neoplasms; Pyrimidines; Sulfonamides; Tumor Microenvironment; Xenograft Model Antitumor Assays

2016